ICU Medical, Inc. (NASDAQ:ICUI) issued an update on its FY17 earnings guidance on Wednesday morning. The company provided EPS guidance of $3.80-4.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.14.
ICU Medical, Inc. (NASDAQ:ICUI) traded down 0.41% during midday trading on Friday, reaching $169.30. The company’s stock had a trading volume of 73,333 shares. The company’s 50-day moving average is $171.58 and its 200 day moving average is $159.92. ICU Medical, Inc. has a 12-month low of $120.15 and a 12-month high of $176.50. The firm has a market cap of $3.36 billion, a price-to-earnings ratio of 67.80 and a beta of 0.37.
ICU Medical (NASDAQ:ICUI) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by $0.06. The business had revenue of $331.51 million for the quarter, compared to the consensus estimate of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The company’s quarterly revenue was up 242.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.15 EPS. Equities analysts forecast that ICU Medical, Inc. will post $4.11 earnings per share for the current year.
ICUI has been the topic of a number of analyst reports. Zacks Investment Research raised ICU Medical from a hold rating to a buy rating and set a $193.00 target price on the stock in a research note on Thursday, July 20th. BidaskClub raised ICU Medical from a hold rating to a buy rating in a research note on Saturday, June 17th. Gabelli reaffirmed a buy rating on shares of ICU Medical in a research note on Friday, August 11th. Sidoti lowered ICU Medical from a buy rating to a neutral rating in a report on Tuesday, June 20th. Finally, Roth Capital lowered ICU Medical from a buy rating to a neutral rating in a report on Thursday, May 11th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $193.00.
In related news, Chairman Vivek Jain sold 100,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $170.80, for a total value of $17,080,000.00. Following the completion of the sale, the chairman now owns 110,925 shares in the company, valued at $18,945,990. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert S. Swinney sold 4,477 shares of the business’s stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $175.00, for a total value of $783,475.00. Following the completion of the sale, the director now owns 23,293 shares of the company’s stock, valued at approximately $4,076,275. The disclosure for this sale can be found here. Insiders sold 203,965 shares of company stock valued at $34,856,920 in the last quarter. 15.90% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This piece was published by Rincon Hill News and is the sole property of of Rincon Hill News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://rinconhillneighbors.org/2017/08/19/icu-medical-inc-icui-issues-fy17-earnings-guidance-updated.html.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with our FREE daily email newsletter.